Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 1844 News Items found Lung Cancer Treatment Advances from MSK Presented at 2025 ASCO Meeting Monday, June 2, 2025 New findings on several important lung cancer clinical trials were presented at the 2025 Annual Meeting of the American Society of Clinical Oncology. Study Provides New Insights Into the Genetic Complexity of Cancer Metastasis Monday, June 2, 2025 A new study from researchers at MSK and Weill Cornell Medicine provides fresh insights about how cancers evolve when they metastasize — insights that could aid in developing strategies to improve the effectiveness of treatment. Article New Drug Combination Improves Survival for ER+, HER2- Breast Cancer Saturday, May 31, 2025 Learn about a three-drug treatment that has been shown to extend survival for ER+, HER2- breast cancers. New Understanding of a Decades-Old Bladder Cancer Treatment Could Help Improve Immunotherapies More Broadly Thursday, May 29, 2025 A team of researchers from MSK and Weill Cornell Medicine is expanding the understanding of how a decades-old treatment for bladder cancer works — an understanding that could help improve the effectiveness of immunotherapies more broadly. Ask the Expert Dense Breast Tissue and Cancer Risk: What You Should Know Tuesday, May 27, 2025 Learn about dense breast tissue and what it means for your cancer risk and screening needs. FDA Expands New Treatment for Metastatic Prostate Cancer: Targets a Protein Called PSMA Tuesday, May 20, 2025 Learn more about a new radiopharmaceutical treatment for prostate cancer approved by the FDA for more patients. MSK Research Highlights, May 19, 2025 Monday, May 19, 2025 New MSK research uncovers new details of the immune response against leptomeningeal metastasis; develops a grading system to assess the risk of developing thrombocytopenia after CAR T cell therapy; and outlines a method for scientists to estimate metabolic characteristics from challenging clinical samples. MSK’s 2025 Convocation Inspires and Honors Achievement Friday, May 16, 2025 At Memorial Sloan Kettering Cancer Center’s 46th annual ceremony, graduating master's and PhD students were honored and award winners were recognized. MSK Researchers Identify Key Player in Childhood Food Allergies: Thetis Cells Thursday, May 15, 2025 Thetis cells, a class of immune cells first described by MSK researchers in 2022, play an essential and previously unknown role in suppressing inflammatory responses to food, a new study finds. FDA Approves Avutometinib-Defactinib Combination for Treating Recurrent Low-Grade Serous Ovarian Cancer With a KRAS Mutation Monday, May 12, 2025 The FDA has approved the first-ever treatment developed for low-grade serous ovarian cancer, a rare type of ovarian cancer. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment